Methadone-Hydrochloride shortage — AU supply status & alternatives

Methadone-Hydrochloride

—

In shortage · Australia

BIODONE FORTE methadone hydrochloride

In declared shortage · 🇦🇺 Australia

Critical shortage

Reading today’s signals…

• Can I substitute?

No pathway on record

prescriber decision required

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Apr 2026

Sponsor est. via TGA — may differ by brand

Product attributes reference data we hold

Active ingredient (INN)	Methadone-Hydrochloride
Brand names	BIODONE FORTE methadone hydrochloride
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Recalls official enforcement reports

🇺🇸

Methadone (A) 2.5Mg In 5Ml Ns Syringe

Sentara Infusion Services · Dec 2022

Class IIdetails ↗

🇨🇦

Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between

Marketed health products · July 2020

Class ?details ↗

🇨🇦

Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect

Marketed health products · Mar 2020

Class ?details ↗

🇺🇸

Methadone Hcl Injection In All Strengths

Pharmedium Services, LLC · Dec 2017

Class IIdetails ↗

🇺🇸

Methadone Hcl

Pharmedium Services, LLC · July 2015

Class IIdetails ↗

🇺🇸

Methadone Hcl

Pharmedium Services, LLC · July 2015

Class IIdetails ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.